Table 3

Significant paths using cycle free effective conductance feature

Prostatic Neoplasms →

Tumor Necrosis Factor-alpha →

NF-κB inhibitor alpha

Prostatic Neoplasms →

RNA, Messenger →

NF-κB inhibitor alpha

Prostatic Neoplasms →

Adenosine Triphosphate →

NF-κB inhibitor alpha

Prostatic Neoplasms →

Oligopeptides →

NF-κB inhibitor alpha

Prostatic Neoplasms →

Tetradecanoylphorbol Acetate →

NF-κB inhibitor alpha

Prostatic Neoplasms →

Cycloheximide →

NF-κB inhibitor alpha


Katukuri et al. BMC Genomics 2012 13(Suppl 3):S5   doi:10.1186/1471-2164-13-S3-S5

Open Data